Literature DB >> 16007622

Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease.

Hideaki Matsui1, Fukashi Udaka, Takafumi Miyoshi, Narihiro Hara, Akiko Tamaura, Masaya Oda, Tamotsu Kubori, Kazuto Nishinaka, Masakuni Kameyama.   

Abstract

Gait disturbance is a cardinal symptom in patients with Parkinson's disease. Among the gait disturbances, freezing of gait is a unique and troublesome symptom, but its mechanism is unclear. We compared brain perfusion images using three-dimensional stereotactic surface projection analysis of N-isopropyl-p-123I iodoamphetamine single photon emission computed tomography between Parkinson's disease patients with freezing of gait and those without. Twenty-four cases (freezing of gait group) with Parkinson's disease with freezing of gait, and 31 Hoehn and Yahr stage-matched cases (no freezing of gait group) with Parkinson's disease without freezing of gait were studied. Bilateral Brodmann area 11 perfusion of the freezing of gait group decreased significantly compared to that of the no freezing of gait group. The Brodmann area 11 may play important roles in gait, and impairment in this region may have a close relationship with freezing of gait in Parkinson's disease. Copyright (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007622     DOI: 10.1002/mds.20520

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  26 in total

1.  The role of the prefrontal cortex in freezing of gait in Parkinson's disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study.

Authors:  Moria Dagan; Talia Herman; Anat Mirelman; Nir Giladi; Jeffrey M Hausdorff
Journal:  Exp Brain Res       Date:  2017-05-16       Impact factor: 1.972

Review 2.  Freezing of gait: understanding the complexity of an enigmatic phenomenon.

Authors:  Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 3.  Freezing of gait in Parkinson's disease.

Authors:  Yasuyuki Okuma
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 4.  What can we learn from freezing of gait in Parkinson's disease?

Authors:  Nina Browner; Nir Giladi
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

5.  Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.

Authors:  Audrey Maillet; Stéphane Thobois; Valérie Fraix; Jérôme Redouté; Didier Le Bars; Franck Lavenne; Philippe Derost; Franck Durif; Bastiaan R Bloem; Paul Krack; Pierre Pollak; Bettina Debû
Journal:  Hum Brain Mapp       Date:  2014-11-19       Impact factor: 5.038

6.  Freezing of gait in older adults with high level gait disorders: association with impaired executive function.

Authors:  N Giladi; V Huber-Mahlin; T Herman; J M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2007-06-18       Impact factor: 3.575

Review 7.  Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation.

Authors:  Elke Heremans; A Nieuwboer; J Spildooren; J Vandenbossche; N Deroost; E Soetens; E Kerckhofs; S Vercruysse
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

Review 8.  Neuroimaging as a window into gait disturbances and freezing of gait in patients with Parkinson's disease.

Authors:  Talia Herman; Nir Giladi; Jeffrey M Hausdorff
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

Review 9.  Imaging: What can it tell us about parkinsonian gait?

Authors:  Nicolaas I Bohnen; Klaus Jahn
Journal:  Mov Disord       Date:  2013-09-15       Impact factor: 10.338

Review 10.  Recent advances in functional neuroimaging of gait.

Authors:  M Bakker; C C P Verstappen; B R Bloem; I Toni
Journal:  J Neural Transm (Vienna)       Date:  2007-07-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.